NCT01266044 2026-04-16
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
Clinical Trials
4,223 trialsNCT02468024 2026-04-16
STABLE-MATES
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT04085276 2026-04-16
TORCHLIGHT
Shanghai Junshi Bioscience Co., Ltd.
Phase 3 Completed
NCT04829539 2026-04-16
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment
University of Rochester
Phase 3 Recruiting
NCT03525873 2026-04-15
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT04852887 2026-04-15
DEBRA
NRG Oncology
Phase 3 Recruiting
NCT05187091 2026-04-15
SWOAR
All India Institute of Medical Sciences
Phase 3 Active not recruiting
NCT06593431 2026-04-15
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT07530887 2026-04-15
NORMA-2
The Netherlands Cancer Institute
Phase 3 Recruiting
NCT01507506 2026-04-14
SPECTRO GLIO
Institut Claudius Regaud
Phase 3 Terminated
NCT02311959 2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3 Completed
NCT03625531 2026-04-14
A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS
The First Affiliated Hospital of Guangzhou Medical University
Phase 3 Completed
NCT04307277 2026-04-14
CHIC-STS01
Institut Claudius Regaud
Phase 3 Recruiting
NCT05581121 2026-04-14
PAROLA
Institut Claudius Regaud
Phase 3 Recruiting
NCT06759636 2026-04-14
FRIENDS-01
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Recruiting
NCT06881992 2026-04-14
Tumor HI
Rezolute
Phase 3 Recruiting
NCT07400523 2026-04-14
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3 Recruiting
NCT07528209 2026-04-14
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 3 Recruiting
NCT07528716 2026-04-14
Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy
Fudan University
Phase 3 Not yet recruiting
NCT07529262 2026-04-14
AspiRe HCC
Curtin University
Phase 3 Not yet recruiting
NCT03271372 2026-04-13
ADAM
University of Washington
Phase 3 Active not recruiting
NCT04939090 2026-04-13
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT05327894 2026-04-13
Interfant-21
Princess Maxima Center for Pediatric Oncology
Phase 3 Recruiting
NCT05417516 2026-04-13
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Recruiting
NCT07469046 2026-04-13
VAH vs VA in Newly Diagnosed Elderly AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3 Not yet recruiting
NCT07524413 2026-04-13
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT01706939 2026-04-09
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Phase 3 Active not recruiting
NCT04547049 2026-04-09
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
First Affiliated Hospital of Zhejiang University
Phase 3 Active not recruiting
NCT04878094 2026-04-09
A Study of Intra-operative Imaging in Women With Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Recruiting
NCT05445791 2026-04-09
METLUNG
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
NCT05852990 2026-04-09
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
NCT06810375 2026-04-09
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
George Washington University
Phase 3 Recruiting
NCT07520578 2026-04-09
SUIVICOLO
University Hospital, Caen
Phase 3 Not yet recruiting
NCT03772028 2026-04-08
OVHIPEC-2
The Netherlands Cancer Institute
Phase 3 Active not recruiting
NCT05050084 2026-04-08
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NRG Oncology
Phase 3 Active not recruiting
NCT06346197 2026-04-08
CIME
Centre Leon Berard
Phase 3 Recruiting
NCT06713837 2026-04-08
IMPACT-AML
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3 Recruiting
NCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT06958328 2026-04-08
LAP100
NRG Oncology
Phase 3 Recruiting
NCT07097142 2026-04-08
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NRG Oncology
Phase 3 Recruiting
NCT07166406 2026-04-08
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
NRG Oncology
Phase 3 Recruiting
NCT03150693 2026-04-07
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Suspended
NCT03583710 2026-04-07
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT03993912 2026-04-07
IFM2017_03
University Hospital, Lille
Phase 3 Active not recruiting
NCT05008848 2026-04-07
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05379153 2026-04-07
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Alliance for Clinical Trials in Oncology
Phase 3 Not yet recruiting
NCT05673148 2026-04-07
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05677490 2026-04-07
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05812807 2026-04-07
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05976763 2026-04-07
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting